摘要
目的:观察肺部疾病炎症早期(痰浊壅肺证)应用活血化瘀药物的临床疗效并探讨其作用机制。
方法:将符合本研究标准的60例患者按照随机、对照的原则分为试验组30例,对照组30例。试验组在西药常规治疗的基础上加用中成药制剂,静滴,每日一次。对照组西药常规治疗。观察两组患者综合疗效、死亡人数、达到目标疗效天数、证候学疗效、治疗前后血液学指标、不良反应等。结果:两者在综合疗效、死亡人数方面无显著差异(p>0.05),但达到目标疗效天数(p<0.01)试验组与对照组相比明显缩短,同样治疗时间内,证候学疗效评定(p<0.01)试验组优于对照组,血液学指标复常情况(p<0.05)试验组优于对照组。
结论:活血化瘀药应用于炎症早期,可以显著改善患者临床症状,控制炎症反应程度。与西医常规药联合应用,可以提高疗效,缩短疗程。其机理可能与活血化瘀药物调节免疫力、抗氧化、清除炎性因子、保护血管内皮细胞、改善微循环及供氧等作用有关。
Objective: to observe the clinical efficacy of drug for promoting blood circulation and removing stasis in the early stage of pulmonary diseases’inflammation(that is, syndrome of turbid phlegm obstructing lung), and explore its mechanism of action.
Methods: according to the principle of random and control, to divide the 60 patients complying with the standard of this research into two groups: 30 people in experimental group and 30 in control group. Treat the experimental group with Chinese medicines on the basis of conventional therapy with western medicine, using intravenous drip once a day. Meanwhile, treat the control group with western medicine only in conventional therapy. To observe the clinical general therapheutic effect, the death amount, the time to reach the objective effect, the syndrome effects, the hematology index before and after the cure and the untoward effects of all patients, and find out the result is: patients of two groups have no significant difference in clinical general therapheutic effect and death amount(p>0.05). But on the time to reach to the objective effect, experimental group(p<0.01) is significantly short than control group. And in the equal period of cure, experimental group’s syndrome effects of (p<0.01) and hematology index are all better than control group.
Conclusion: drug for promoting blood circulation and removing stasis should be applied into the early stage of inflammation, which can noticeably improve patients’clinical efficacy and control the reaction degree of inflammation. To combine western medicines with Chinese medicines together into disease cure can promote clinical effectiveness and shorten time of treatment. The mechanism of the above phenomenon may lie in the remakable healing efficacy of drug for promoting blood circulation and removing stasis on enhancing immunity, resisting oxidation, clearing inflammatory factor, protecting vascular endothelial cells, improving the microcirculation and and supplying oxygen and so on.
引文
[1]刘先胜,徐永健.慢性阻塞性肺疾病发病机制的研究进展[J].中国呼吸与危重监护杂志,2004,3(2):70
[2]郑鑫,整体看待上下呼吸道全面治疗呼吸道炎症[J].中国医学论坛报,2009-03-26
[3]李榜龙,李文朴.单核-巨噬细胞在急性呼吸窘迫综合征发病机制中的作用[J].中国实用医药,2001,1(5):246-248
[4]李美容,王敏.IL-12和支气管哮喘[J].生命的化学,2010,30(1):119-122
[5]刘先胜,徐永健.慢性阻塞性肺疾病发病机制的研究进展[J].中国呼吸与危重监护杂志,2002.,3(3):70-72
[6]崔青松,金明根.细胞因子及炎性介质在急性呼吸窘迫综合征中的作用研究进展[J].延边大学医学学报,2009,3(1):67-71
[7]刘真,肖斌等.炎症与肿瘤的关系研究进展[J].现代生物医学进展,2009,9(3):591-594
[8]张晓鸣,杜国有.C -反应蛋白对炎症性疾病的诊断价值[J].右江民族医学院学报,2002,4:540-541
[9]曹占良,步天栩等.定量C -反应蛋白测定的临床意义[J].天津医科大学学报,2003,9(2):259-260
[10]张粹昌.中医辨证”炎症”虚实[J].中国现代药物应用,2009,4(7):186-187
[11]舒惠荃,王宝山等.正邪交争与炎性反应[J].现代中西医结合杂志,2006,15(16):2157-2158
[12]吴祎,朱勣.活血化瘀法治疗肺部感染[J].黑龙江中医药,2010,2:57-58
[13]蔡华荣,向小勇.炎性反应与急性肺损伤的关系研究进展[J].中国体外循环杂志,2006,4(2):125-127
[14]陈玉娟.气道重塑的治疗研究进展[J].新医学,2008,39(3):208-210
[15]朱雄翔,汤朝武,陈璧.烧伤早期及丹参对中性粒细胞化学发光的影响.第四军医大学学报, 1999, 20 (10) : 924
[16]王志华,邢淑丽.慢阻肺患者的血液流变学观察[J].天津中医学院学报,1994,3:34-36
[17]刘鑫.脉络宁治疗慢阻肺伴高黏血症的疗效观察[J].现代中西医结合研究杂志,2003,12(3):241-242
[18]赵彦芬,程显声,邵茂刚等.慢性肺源性心脏病血液动力学与血流变学的相关分析[J] .中华结核和呼吸杂志,1991,14(1):11
[19]郭颂铭,华斌,柏连松.复方丹参凝胶对感染创面炎症介质及其基因表达的影响[J].江西医学院学报,2002,42(6):5-8
[20].Smith PD ,Polo M,Soler PM,et al . Efficacy of growth factors in accelerated closure of interstices in explanted meshed human skin grafts[J].J Burn Rehabil ,2000,21(3):5-9.
[21]曹来安.碱性成纤维细胞生长因子修复表皮剥脱性创面的临床观察[J].中国修复重建外科杂志,2000,14 5):319-321.
[22] Ke MJ,Hang ZL,Zhen D.The effects of Compositive SalviaMiltiorrhizel parenteral solution treating heart failure of pulmonary heart disease patients.[J]Practical clinics emergency of integrated traditional and western medicine.1996,3(4);160～162[柯美金,黄治娇,郑莉。复方丹参液治疗肺心病心力衰竭的疗效观察[J].中西医结合实用临床急救,1996,3(4):160～162
[23] Shen BL,Xu YY,Qi H.Experimental study of compositive Salvia Miltiorrhiza injection on respiratory distress syndrome induced by oleic acid in rabbits.Tianjin J,2000,28(5);293～294[沈炳玲,徐燕燕,齐虹。复方丹参注射液对兔油酸型呼吸窘迫综合征影响的实验研究[J].天津医药,2000,28(5):293～294
[24] Xu YD,Xiao ZL,Luo W.et al.Experimental study of an animal model of early acute respiratory distress syndrome with acutehemorrhagic shock followed by intravenous injection of low doseendotoxin.Chinese Critical Care Medicine,2000,12(5);276～280[徐远达,萧正伦,罗炜等。急性低血容量休克后低剂量内毒素致早期急性呼吸窘迫综合征动物模型研制。[J]中国危重病急救医学,2000,12(5):276～280]
[25]姜树本,张海.活血化瘀药治疗机制初探[J].临床荟萃,1996,11(17):803-804
[26]阮成伟.对活血化癖法治疗炎症的认识[J].现代中西医结合杂志,2008,17(3):354一355.
[27]幻施毅,宋勇.现代肺部感染学[M]北京:人民军医出版社,1996:116.
[28]欧艳娟.肺部感染为何多用活血化瘀法[J]辽宁中医药大学学报,2008,10(1):13一14.
[29]唐发武,张翠萍.活血化瘀法为主治疗小儿肺炎100例[J].现代中医药,2003(4):26
[30]朱雄翔,汤朝武,陈璧.烧伤早期及丹参对中性粒细胞化学发光的影响[J].第四军医大学学报,1999,20(10):924
[31]李爱顺,黄佐.冠心病中西医抗氧化治疗进展[J].中国中西医结合杂志,1996,16(1):61
[32]张健,曹恩华,秦静芬,等.抗氧化剂对DNA损伤的保护作用机制的研究[J].生物物理学报, ,1997,13(1):123-127
[33]赵燕,江文,侯京武,等.钙过负荷和丹参酮对线粒体脂质过氧化的影响[J].生物化学与生物物理学报,1995,27(6):610-615
[34]李建晴,展青,高继才等.丹参酮及其金属配合物的抗菌活性[J].山西医科大学学报,1999,(增刊):92-93
[35]万敬员,叶笃筠,吴萍,等.川芎嗪对脂多糖诱导巨噬细胞环氧化酶22表达和心肌细胞凋亡的影响[J].中国中西医结合杂志,2004,24(10):906-11.
[36]孙志伟,王翠莲.川芎嗪对血液流变学指标影响的研究[J].中华实用中西医杂志,2005,18(6):783-4.
[37]李自成,李丽,严亨秀,等.川芎嗪对缺氧所致大鼠呼吸效应和脑干神经元型一氧化氮合酶表达的影响[J].生理学报,2005,57(2):147-53.
[38]马静,马玲.中药川芎中有效成分及药理作用研究进展[J].中国民族民间医药,2009,19:9-10
[39]高笑舸,崔桅.中药对血管内皮细胞保护作用的研究概况[J].天津药学,2003,15(2):42
[40]张志琳,吴鸿飞,包仕尧,等.血管内皮细胞缺氧性损伤及药物干预作用的实验观察.江西医药,1998,24(11):805
[41]杨冬梅,李海涛.中药抗炎免疫药理研究进展[J].中国中医急症,2006,15(11):1278-1280
[1]刘先胜,徐永健.慢性阻塞性肺疾病发病机制的研究进展[J].中国呼吸与危重监护杂志,2004,3(2):70
[2]郑鑫,整体看待上下呼吸道全面治疗呼吸道炎症[J].中国医学论坛报,2009-03-26
[3]李榜龙,李文朴.单核-巨噬细胞在急性呼吸窘迫综合征发病机制中的作用[J].中国实用医药,2001,1(5):246-248
[4]李美容,王敏.IL-12和支气管哮喘[J].生命的化学,2010,30(1):119-122
[5]刘先胜,徐永健.慢性阻塞性肺疾病发病机制的研究进展[J].中国呼吸与危重监护杂志,2002.,3(3):70-72
[6]崔青松,金明根.细胞因子及炎性介质在急性呼吸窘迫综合征中的作用研究进展[J].延边大学医学学报,2009,3(1):67-71
[7]刘真,肖斌等.炎症与肿瘤的关系研究进展[J].现代生物医学进展, 2009, 9(3): 591-594
[8]王志华,邢淑丽.慢阻肺患者的血液流变学观察[J].天津中医学院院报,1994,3:35-36
[9]姜树本,张海.活血化瘀药治疗机制初探[J].临床荟萃.1996,11(17):803-804
[10]韩明向,王亿平.活血化瘀治疗慢性阻塞性肺疾病及肺心病的研究概况[J].安徽中医学院学报,1990,9(1):58-61
[11]吕金星.中性粒细胞凋亡与细胞因子[J].国外医学创伤与外科基本问题分册,1999,20(4):210
[12]陈晔.慢性阻塞性肺疾病气道重构研究进展[J].浙江中西医结合杂志,2009,19(8):526-528
[13] Pesci A, Rossi GA, Bertorelli G, et al. Mast cells in the airway lumen and bronchial mucosa of patientswith chronicbronchitis. Am J Resp ir Cirt Care Med ,1994,149(5):131121316
[14] GrashoffWF, Sont JK, Sterk PJ, et al. Chronic obstructive pulmonary disease: role of bronchiolarmast cells and macrophages. Am J Pathol, 1997, 151 (6) : 178521790
[15]刘景艳,修清玉.细胞因子在慢性阻塞性肺疾病发病中的作用[J].国外医学呼吸系统分册,2005,25(6):420—422.
[16]侯静静,朱蕾.白介素一8与慢性阻塞性肺疾病[J].国外医学呼吸系统分册,2005.25(6):428—429.
[17] Noguera A ,Bade S,M iralles C.et a1.Enhanced neutrophic response in chronic obstructive pulmonary disease[J].Thorax,2001,56(6):432—437.
[18] Cosio MG, Guerassimor A. Chronic obstructive pulmonary disese inflammation of small airway and lung parenchyma.Am J Resp ir Crit CareMed, 1999, 160 (5) : 5212525
[19] Wang D, Zheng T, Zhu Z, et al. Interferon2gamma induction of pulmonary emphysema in The adultmurine lung. J ExpMed, 2002, 192 (11) : 158721600
[20]张晓鸣,杜国有.C -反应蛋白对炎症性疾病的诊断价值[J].右江民族医学院学报,2002,4:540-541
[21]曹占良,步天栩等.定量C -反应蛋白测定的临床意义[J].天津医科大学学报,2003,9(2):259-260
[22] Holgate ST. Airway wall remodeling. Eur Resp ir Rev, 2000,10: 69, 58263
[23] Leafant C et al. International Consensus Report on Diagnosis and Treatment of Asthma
[24] Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function [J].Annu Rev Nutr, 2002, 22: 439-458
[25] Blease K,Lukacs NW,Hogaboam CM,et al. Chemokines and their role in airway hyper- reactivity[J].Respir Res,2000,1:54- 61.
[26]张粹昌.中医辨证”炎症”虚实[J].中国现代药物应用,2009,4(7):186-187
[27]舒惠荃,王宝山等.正邪交争与炎性反应[J].现代中西医结合杂志,2006,15(16):2157-2158
[28]李建晴,展青,高继才等.丹参酮及其金属配合物的抗菌活性[J].山西医科大学学报,1999,(增刊):92-93
[29]王玉芹,杨树东,李家实等.红花黄色素对血小板活化因子介导的中性粒细胞功能的影响[J].北京中医药大学学报,2000,23(4):21
[30]林勇,高存记,黎健等.槲皮素对TN FA诱导的内皮细胞与中性粒细胞黏附的抑制作用.药学学报, 1999, 34 (7) : 491
[31]曹春水,黄亮.复方丹参对早期急性肺损伤炎性介质的影响[J].江西医药,2007,42(3):208-211
[32]郭颂铭,华斌等,复方丹参凝胶对感染创面炎症介质及其基因表达的影响[J].江西医学院院报,2002,42(6):5-8
[33]黄亮,史雪梅等.丹参酮ⅡA对急性肺损伤大鼠保护作用的实验研究[J].第十一次全国急诊医学学术交流会论文集,基础研究摘要